HighTower Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

HighTower Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-16,974	Closed	-$3.13M	–	3559
2021 Q2	$3.13M	Buy	16,974 +653	+4%	+$112K	0.01%	990
2021 Q1	$2.49M	Sell	16,321 -20,891	-56%	-$3.23M	0.01%	1020
2020 Q4	$5.81M	Buy	37,212 +18,909	+103%	+$2.43M	0.02%	544
2020 Q3	$2.09M	Buy	18,303 +5,752	+46%	+$621K	0.01%	857
2020 Q2	$1.4M	Buy	12,551 +7,044	+128%	+$748K	0.01%	959
2020 Q1	$495K	Buy	+5,507	New	+$540K	﹤0.01%	1335
2019 Q4	–	Sell	-4,299	Closed	-$420K	–	2599
2019 Q3	$420K	Sell	4,299 -677	-14%	-$76.3K	﹤0.01%	1606
2019 Q2	$655K	Buy	4,976 +358	+8%	+$46.1K	﹤0.01%	1387
2019 Q1	$628K	Buy	4,618 +181	+4%	+$22.5K	﹤0.01%	1347
2018 Q4	$431K	Sell	4,437 -859	-16%	-$102K	﹤0.01%	1433
2018 Q3	$739K	Buy	5,296 +499	+10%	+$62.6K	0.01%	1270
2018 Q2	$592K	Buy	4,797 +337	+8%	+$39.4K	﹤0.01%	1370
2018 Q1	$493K	Sell	4,460 -4	-0.1%	-$478	﹤0.01%	1421
2017 Q4	$535K	Sell	4,464 -3,886	-47%	-$473K	﹤0.01%	1418
2017 Q3	$1.17M	Buy	8,350 +5,363	+180%	+$729K	0.01%	1018
2017 Q2	$361K	Sell	2,987 -13,070	-81%	-$1.52M	﹤0.01%	1530
2017 Q1	$1.93M	Sell	16,057 -338	-2%	-$43.6K	0.02%	771
2016 Q4	$1.99M	Sell	16,395 -1,240	-7%	-$152K	0.02%	705
2016 Q3	$2.15M	Buy	17,635 +375	+2%	+$48.3K	0.02%	640
2016 Q2	$2.03M	Sell	17,260 -6,217	-26%	-$882K	0.03%	622
2016 Q1	$3.26M	Sell	23,477 -4,652	-17%	-$683K	0.04%	530
2015 Q4	$5.38M	Buy	28,129 +11,222	+66%	+$1.96M	0.06%	320
2015 Q3	$2.65M	Buy	+16,907	New	+$3.08M	0.04%	512
2015 Q2	–	Sell	-13,124	Closed	-$2.27M	–	1760
2015 Q1	$2.27M	Sell	13,124 -4,992	-28%	-$904K	0.03%	545
2014 Q4	$3.35M	Buy	18,116 +246	+1%	+$45.6K	0.05%	405
2014 Q3	$2.96M	Sell	17,870 -561	-3%	-$92.1K	0.05%	414
2014 Q2	$2.88M	Buy	18,431 +1,211	+7%	+$191K	0.05%	436
2014 Q1	$2.62M	Buy	17,220 +1,836	+12%	+$292K	0.05%	429
2013 Q4	$2.04M	Buy	+15,384	New	+$1.85M	0.04%	455

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return